Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) fell by -7.40% during last session from $5.00 to $4.63 and has now fallen 4 consecutive sessions. The price has fallen in 6 of the last 10 days and is down by -12.14% over the same course of time. Volume has increased during last session by 0.65 million shares, but on a weak note. This is may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.09 M shares exchanged hands for about $5.05 million.
Inside PIRS’s Recent Trend
Pieris Pharmaceuticals, Inc. (PIRS) has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $5.19. A reaction back to this level may hold a second chance to get out before further falls.
Pieris Pharmaceuticals, Inc. Technical Signals
PIRS has witnessed its long term and short term MA triggering a sell signal. Many traders watch for long-term averages to cross above short-term averages to signal the beginning of a downtrend. Upon corrections, the price will meet resistance from the averages between $5.07 and $5.35. A buy signal will be generated if it crosses above any of these levels. Its pivot point high generated sell signal on Monday August 07, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. Volume up and price depreciating is getting our attention as this movement is seen as bearish sign.
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Support And Resistance Levels
Pieris Pharmaceuticals, Inc. (PIRS) recorded volume accumulation so there will probably be a surplus of buyers at $4.62. In case of gains, the next resistance from accumulated volume will not be far away from today’s level at $4.85, $5.06 and $5.44.
Accumulated volume is going to prevent the price from rising further at $4.85 and this action will lead the price to take a temporary pause or stay muted for a few days.
Pieris Pharmaceuticals, Inc. (PIRS) Risk Assessment
A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $0.65 between high and low, or 14.54%. The average volatility for the past week stood at 6.66%.
Pieris Pharmaceuticals is in oversold territory based on Relative Strength Index reading (23). In some cases it takes more time for the trend to shift while the stock is being oversold and the Relative Strength Index keeps moving.